Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study to Evaluate Combination Anti-malarial Therapy,in Terms of Efficacy, Prevalence of Gametocyte Carriage and Molecular Markers Associated With Sulfadoxine Pyrimethamine Resistance in Uncomplicated Plasmodium Falciparum

NCT00203801 is registered in ClinicalTrials.gov with University of Cape Town as lead sponsor.

NCT NCT00203801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00203801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study to Evaluate Combination Anti-malarial Therapy,in Terms of Efficacy, Prevalence of Gametocyte Carriage and Molecular Markers Associated With Sulfadoxine Pyrimethamine Resistance in Uncomplicated Plasmodium Falciparum
Lead sponsor
University of Cape Town
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2002
Completion date
July 31, 2005
Enrollment
700
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

malaria